Breaking: FDA Approves Oral Wegovy, Expanding Weight Loss Treatment Access The FDA has approved oral Wegovy (semaglutide) for obesity treatment, marking a significant advancement in weight management therapy accessibility. This oral formulation removes injection barriers while offering the most affordable self-pay pricing to date in the GLP-1 drug class. Key